Profiel
Amy VandenBerg worked as a Vice President of Regulatory and Clinical Affairs at Obalon Therapeutics, Inc. from 2014 to 2019.
Prior to that, she worked as a Director of Regulatory Affairs at DexCom, Inc. from 2006 to 2008 and as a Manager of Clinical Trials at Cygnus, Inc. Additionally, she earned an undergraduate degree from St. Mary's College of California in 1998.
Eerdere bekende functies van Amy VandenBerg
Bedrijven | Functie | Einde |
---|---|---|
DEXCOM, INC. | Algemeen Adviseur | 01-12-2008 |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
RESHAPE LIFESCIENCES INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Amy VandenBerg
St. Mary's College of California | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DEXCOM, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |